Industry News
Medical device news
ImpediMed, KarmelSonics, Nanosonics [ + ]
Garvan keeps prize to itself
Garvan Institute researcher wins type 2 diabetes fellowship [ + ]
Silent suppression for Antisense
ATL1101 suppresses prostate tumour growth in animal models [ + ]
CSL hopes for big profit
CSL predicts strong FY09 despite market crisis [ + ]
Bonobos and the evolution of male aggression
German researchers observe male and female bonobos hunting other primates [ + ]
Chicken soup for the blood
Proteins from chicken legs have ACE-inhibitor effect [ + ]
Alzheimer's disease research attracts first partner
Pfitzer Australia, with the Australian Imaging, Biomarker and Lifestyle Flagship Study of Ageing, is going to investigate the causes of Alzheimer’s disease and aims to discover a method for early diagnosis.
[ + ]Alzheimer’s study gets funding boost
Pfizer Australia invests in CSIRO Alzheimer’s biomarker study [ + ]
ChemGenex completes SPP
ChemGenex raises $13m for late-stage R&D [ + ]
ImClone licenses VEGFR antibody
ImClone to develop Vegenics’ VEGFR-3 inhibitor as pre-clinical candidate [ + ]
Bald times two
Two studies find genetic risk factors for male pattern baldness [ + ]
Thermophilus and its proton pump
The structure of another membrane protein has been determined, this time a polysulfide enzyme in Thermus thermophilus. [ + ]
Malaria genomes under the knife
Genomes of two malaria parasite species sequenced [ + ]
The relative differences of the malaria family
Toby Sargeant has used new statistical techniques to trace the evolutionary development of the Plasmodium species of parasites and the relationship between different clades. [ + ]
Malaria’s potentially fatal weakness
Alan Cowman’s group from WEHI may have found a weakness in the armour of the malaria parasite – by harnessing P. falciparum’s key defence strategy, they plan to turn it against itself. [ + ]
